Bath & Body Works (BBWI) – A Look at the Fundamentals

By Naomi Wentworth • Monday, December 11 16:43 • Permanent Link

With gains of 3.2%, Bath & Body Works was one of the winners on Wall Street today. Its shares are now trading at $38.79 and have logged a 0.0% daily outperformance of the S&P 500. Don't join the feeding frenzy before checking some basic facts about this stock:

Bath & Body Works has moved -10.9% over the last year, and the S&P 500 logged a change of 15.4%
BBWI has an average analyst rating of buy and is -4.08% away from its mean target price of $40.44 per share
Its trailing earnings per share (EPS) is $3.14
Bath & Body Works has a trailing 12 month Price to Earnings (P/E) ratio of 12.4 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $3.3 and its forward P/E ratio is 11.8
Bath & Body Works is part of the Consumer Cyclical sector, which has an average P/E ratio of 22.96 and an average P/B of 4.24
BBWI has reported YOY quarterly earnings growth of 30.3% and gross profit margins of 0.4%
The company has a free cash flow of $575.25 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.